Command Palette

Search for a command to run...

Clinical Trials · NCT01215968

A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes Mellitus

CompletedPhase 1Dulaglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Eli Lilly and Company
Enrollment
38
Start date
Sep 2010
Locations
1 site, United Kingdom
Primary endpoint
Time Required for 50% of Radioactivity To Be Emptied From the Stomach by Scintigraphy
View Dulaglutide compound reference